Yohan Suryo Rahmanto
Overview
Explore the profile of Yohan Suryo Rahmanto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asaka S, Liu Y, Yu Z, Suryo Rahmanto Y, Ono M, Asaka R, et al.
Mod Pathol
. 2023 Feb;
36(2):100045.
PMID: 36853791
Loss of progesterone receptor (PR) expression is an established risk factor for unresponsiveness to progesterone therapy in patients with endometrial atypical hyperplasia and endometrioid carcinoma. ARID1A is one of the...
2.
Padilla M, Binju M, Wan G, Suryo Rahmanto Y, Kaur P, Yu Y
Cancer Drug Resist
. 2022 May;
2(4):1127-1135.
PMID: 35582283
Investigating the biological processes that occur to enable recurrence and the development of chemoresistance in ovarian cancer is critical to the research and development of improved treatment options for patients....
3.
Shen Y, Jung J, Shimberg G, Hsu F, Suryo Rahmanto Y, Gaillard S, et al.
iScience
. 2021 Nov;
24(11):103297.
PMID: 34816098
PBX1 is a transcription factor involved in diverse cellular functions including organ development, stem cell renewal, and tumorigenesis. is localized at chr1q23.3, a frequently amplified chromosomal region, and it is...
4.
Shen Y, Hong J, Asaka R, Asaka S, Hsu F, Suryo Rahmanto Y, et al.
Cancer Res
. 2020 Aug;
80(20):4514-4526.
PMID: 32859605
Amplification and overexpression of the oncogene in tumor cells, including ovarian cancer cells, correlates with poor responses to chemotherapy. As MYC is not directly targetable, we have analyzed molecular pathways...
5.
Suryo Rahmanto Y, Shen W, Shi X, Chen X, Yu Y, Yu Z, et al.
Nat Commun
. 2020 Jun;
11(1):2717.
PMID: 32483112
Somatic inactivating mutations of ARID1A, a SWI/SNF chromatin remodeling gene, are prevalent in human endometrium-related malignancies. To elucidate the mechanisms underlying how ARID1A deleterious mutation contributes to tumorigenesis, we establish...
6.
Bae D, Lane D, Siafakas A, Sutak R, Paluncic J, Huang M, et al.
Biochim Biophys Acta Mol Basis Dis
. 2020 Jun;
1866(10):165844.
PMID: 32480040
The iron-containing protein, acireductone dioxygenase 1 (ADI1), is a dioxygenase important for polyamine synthesis and proliferation. Using differential proteomics, the studies herein demonstrated that ADI1 was significantly down-regulated by cellular...
7.
Binju M, Amaya-Padilla M, Wan G, Gunosewoyo H, Suryo Rahmanto Y, Yu Y
Cancers (Basel)
. 2019 Nov;
11(11).
PMID: 31766284
Ovarian cancers remain one of the most common causes of gynecologic cancer-related death in women worldwide. The standard treatment comprises platinum-based chemotherapy, and most tumors develop resistance to therapeutic drugs....
8.
Yu Y, Suryo Rahmanto Y, Shen Y, Ardighieri L, Davidson B, Gaillard S, et al.
EBioMedicine
. 2019 Sep;
47:184-194.
PMID: 31492560
Background: Spleen tyrosine kinase (SYK) is frequently upregulated in recurrent ovarian carcinomas, for which effective therapy is urgently needed. SYK phosphorylates several substrates, but their translational implications remain unclear. Here,...
9.
Park Y, Chui M, Suryo Rahmanto Y, Yu Z, Shamanna R, Bellani M, et al.
Clin Cancer Res
. 2019 Jun;
25(18):5584-5594.
PMID: 31196855
Purpose: Somatic inactivating mutations in ARID1A, a component of the SWI/SNF chromatin remodeling complex, are detected in various types of human malignancies. Loss of ARID1A compromises DNA damage repair. The...
10.
Chen L, Huang R, Chan M, Yan P, Huang T, Wu R, et al.
J Pathol
. 2019 Mar;
248(3):363-376.
PMID: 30883733
Ten-eleven translocation methylcytosine dioxygenase-1, TET1, takes part in active DNA demethylation. However, our understanding of DNA demethylation in cancer biology and its clinical significance remain limited. This study showed that...